The invention set forth in the claims relates generally to wound therapy and more particularly, but without limitation, to an anatomical training and demonstration model for negative pressure and instillation therapy.
Wound care is a complex field that attempts to manage and heal many types of wounds at various anatomical locations on a patient. To further complicate matters, patients often have difficult and complicated accompanying health issues. Proficiency in wound care can take years of advanced training and exposure to many patients in order to encounter the wide range of clinical situations, therapy options, and potential patient outcomes. A wound treatment training aid can help to simulate various wound types, complexities, and therapy options available to clinicians. A training device may also be used to simulate the dynamic, complicated, and often convoluted healing trajectory as wounds progress. Some common issues in wound therapy include ease of use, efficiency in application and healing, and proper drainage of exudates. To date, there is no art that adequately addresses these challenges. Thus, there is a need for a reusable training aid that allows for wound dressing application practice incorporating components typically used in the field.
The present disclosure overcomes drawbacks of previously-known art by providing a device, system, and method incorporating a wound model made from elastomeric materials that may simulate the look and feel of skin. In some embodiments, the use of transparent materials allows a view of the simulated dressing-wound bed interface during therapy. The device may include a wound bed and simulated anatomical features imperative to wound therapy setup and application.
The modular wound therapy device may include a support tray. The device may further have an elastic insert sized to fit securely within the tray and the insert further may have a base. The base may have a recess that is circumferentially smaller than the base. The device further may have a conformable polymer sized to fit within the recess. A dressing may be configured to be adhered on top of the elastic insert, and a negative pressure source may be configured to be coupled to the dressing. In some preferred embodiments, the base represents a periwound and the recess represents a wound bed.
In one embodiment, the elastic insert may be made of a transparent rubber having a resiliency and compressibility intended to simulate a human body portion. In certain embodiments, one or more wound bed inserts may be made of, but not limited to, dermasol, pectin, collagen and dehydrated plasma proteins integrated into woven viscous, cellulose membrane, or hydrocolloid. In some embodiments, the wound bed insert further may be made of a plurality of hydrocolloid strips. In one embodiment, the wound bed insert may have an image of a wound on at least one surface.
In certain embodiments, the tray of the device may be transparent. In other embodiments, the tray may have borders colored to depict a patient's skin. Water may be circulated within the device to maintain a desired temperature. The device may include contouring to match specific patient anatomies, including, but not limited to, an intergluteal cleft.
The device further may be operatively coupled to one or more sensors. The one or more sensors may supply readings to a software program indicating pressure levels of a treatment site. A plurality of force sensors may be distributed in an array around the insert to determine applied force.
The device may further have a peristaltic pump that extrudes a liquid from within the base either in or around the wound bed. The device also may have a negative pressure cutout depicted on the insert with the appropriate dimensions to serve as a reference cutout for users. In one embodiment, a heater also may be added to the base to represent body temperature or display redness to demonstrate the impact of a potential treatment. In some embodiments, a clear dermasol object may included (e.g. be packed between the insert and the tray) to simulate tunneling wounds and undermined areas.
A plurality of wound bed inserts may be sized to fit in the recess of the base. In some embodiments, more than one wound bed insert may fit in one recess. In some embodiments, the dressing may be applied about three centimeters from an outer circumferential border of the base.
A wound therapy training system is also provided. The training system may be made up of any of the devices described above aligned to demonstrate multiple wound treatment sites. The plurality of devices may be aligned in series, in parallel, or in other combinations and alignments demonstrating multiple treatment sites.
A method of simulating negative pressure wound therapy is also provided. The method includes assembling the modular device described above and activating the negative pressure source. Alterations of pressure or materials allows the user to recreate a variety of treatment conditions and different types of treatment. In some methods, the device demonstrates wounds on a continuum. The continuum may include, but is not limited to, wounds with non-viable tissue, slough in a wound bed, wounds requiring debridement, and wounds requiring granulation.
In one embodiment of the method, the experiment conditions are 1 cycle with about a 10-minute soak and about 30 minutes of negative pressure wound therapy at about 125 mmHg. In another embodiment, experiment conditions are 10 cycles with about a 20-minute soak and about 45 minutes of negative pressure wound therapy at about 125 mmHg. In yet another embodiment of the method, experiment conditions make up 8 cycles with about a 10-minute soak and 3.5 hours of negative pressure wound therapy at 125 mmHg negative pressure.
A user may create a real-time visualization of wound bed deformation by viewing any side of the device while performing the methods described above. The method further may allow a user to observe macrostrain in a simulated wound bed.
A modular training device for negative pressure and installation therapy is provided herein. The modular device illustratively may include a support tray, an elastic insert, a base within the elastic insert, a recess within the base, a conformable polymer, a dressing and a negative pressure source. The recess may be circumferentially smaller than the base and the conformable polymer may be sized to fit within the recess. The dressing may be configured to adhere on top of the elastic insert, and the negative pressure source may be configured to be coupled to the dressing.
Referring to
As shown in
Referring to
As shown in
As shown in
Device 10 further may have a heater in base 104 to represent body temperature or inflammation. Device 10 further may display redness, from a heated, electronic, or other source, to demonstrate the impact of a potential treatment or to indicate where a trainee has made a mistake in their use of device 10. In some embodiments, device 10 may also have at least one clear dermasol object packed within a suitable elongated cavity within insert 102 (or between insert 102 and tray 100) to simulate a tunneling wound or an undermined skin healing area.
Referring to
A wound therapy training system is also disclosed. Referring to
A method of simulating negative pressure wound therapy is also provided. In one embodiment of the method, modular device 10 is assembled and negative pressure source 110 is activated.
The method may demonstrate wounds on a continuum. For example, the method can demonstrate, among other common wound therapy stages: non-viable tissue, slough in a wound bed, wounds requiring debridement, and wounds requiring granulation. The method may be used with multiple experiment conditions. One exemplary experiment condition includes about 1 cycle with about a 10-minute soak and about 30 minutes of negative pressure wound therapy at about 125 mmHg. Another exemplary experiment includes about 10 cycles with about a 20-minute soak and about 45 minutes of negative pressure wound therapy at about 125 mmHg. Yet another exemplary experiment includes about 8 cycles with about a 10-minute soak and 3.5 hours of negative pressure wound therapy at 125 mmHg.
In some embodiments, the training aid could be used in a simulation lab to provide more in-depth training on various applications of the V.A.C. ULTA™ System and its therapy settings in more realistic scenarios, including, but not limited to, wounds that require debridement or those that only require granulation. Use in such a manner is intended to couple actual patient therapy devices with the simulated wound so that real time status feedback to the trainee on issues such as dressing leakage, fluid tube blockage, and any other indicators or alarms that may be relevant to the particular dressing type. The device and method can simulate a desired, normal healing trajectory for wounds that are progressing to closure as well as wounds that regress or fail to response and need alternative therapy options. For instance, the device can simulate an increase in common signs of an infected wound (redness and heat) and demonstrate the impact of potential treatment alterations and strategies to mitigate and manage therapy states, including pressure monitoring at the wound bed and screens to display the readings. It may be particularly useful in describing dynamic pressure control (DPC) and its effects on modulating applied negative pressure to the wound bed. Furthermore, a port in the base may be included to deliver a fluid to the wound bed to simulate exudate. Alternatively, the base may include small openings or perforations that would permit a fluid to be drawn into recess 105 under negative pressure to simulate development of exudate from the wound bed.
While various illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made therein without departing from the invention. The appended claims are intended to cover all such changes and modifications that fall within the true scope of the invention.
The present application claims the benefit of priority to U.S. Patent Application No. 62/767,822, filed on Nov. 15, 2018, the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1355846 | Rannells | Oct 1920 | A |
2547758 | Keeling | Apr 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Nov 1959 | A |
2969057 | Simmons | Jan 1961 | A |
3066672 | Crosby, Jr. et al. | Dec 1962 | A |
3367332 | Groves | Feb 1968 | A |
3520300 | Flower, Jr. | Jul 1970 | A |
3568675 | Harvey | Mar 1971 | A |
3648692 | Wheeler | Mar 1972 | A |
3682180 | McFarlane | Aug 1972 | A |
3826254 | Mellor | Jul 1974 | A |
4080970 | Miller | Mar 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4139004 | Gonzalez, Jr. | Feb 1979 | A |
4165748 | Johnson | Aug 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4233969 | Lock et al. | Nov 1980 | A |
4245630 | Lloyd et al. | Jan 1981 | A |
4256109 | Nichols | Mar 1981 | A |
4261363 | Russo | Apr 1981 | A |
4275721 | Olson | Jun 1981 | A |
4284079 | Adair | Aug 1981 | A |
4297995 | Golub | Nov 1981 | A |
4333468 | Geist | Jun 1982 | A |
4373519 | Errede et al. | Feb 1983 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4392858 | George et al. | Jul 1983 | A |
4419097 | Rowland | Dec 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4475909 | Eisenberg | Oct 1984 | A |
4480638 | Schmid | Nov 1984 | A |
4525166 | Leclerc | Jun 1985 | A |
4525374 | Vaillancourt | Jun 1985 | A |
4540412 | Van Overloop | Sep 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4551139 | Plaas et al. | Nov 1985 | A |
4569348 | Hasslinger | Feb 1986 | A |
4605399 | Weston et al. | Aug 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
4640688 | Hauser | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4664662 | Webster | May 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4733659 | Edenbaum et al. | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4758220 | Sundblom et al. | Jul 1988 | A |
4787888 | Fox | Nov 1988 | A |
4826494 | Richmond et al. | May 1989 | A |
4838883 | Matsuura | Jun 1989 | A |
4840187 | Brazier | Jun 1989 | A |
4863449 | Therriault et al. | Sep 1989 | A |
4872450 | Austad | Oct 1989 | A |
4878901 | Sachse | Nov 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4906240 | Reed et al. | Mar 1990 | A |
4919654 | Kalt | Apr 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4953565 | Tachibana et al. | Sep 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4985019 | Michelson | Jan 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5086170 | Luheshi et al. | Feb 1992 | A |
5092858 | Benson et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215522 | Page et al. | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5278100 | Doan et al. | Jan 1994 | A |
5279550 | Habib et al. | Jan 1994 | A |
5298015 | Komatsuzaki et al. | Mar 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5437622 | Carion | Aug 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
6071267 | Zamierowski | Jun 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6241525 | Spitalnik | Jun 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
7850454 | Toly | Dec 2010 | B2 |
7862339 | Mulligan | Jan 2011 | B2 |
7887330 | King | Feb 2011 | B2 |
8057236 | Miau | Nov 2011 | B2 |
8635921 | Eckstein | Jan 2014 | B2 |
9472121 | Pravong | Oct 2016 | B2 |
9974890 | Hudspeth | May 2018 | B2 |
10586470 | Parry | Mar 2020 | B2 |
10726743 | Segall | Jul 2020 | B2 |
10803761 | Welch | Oct 2020 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020115951 | Norstrem et al. | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20170193858 | Segall | Jul 2017 | A1 |
20200349864 | Hanna | Nov 2020 | A1 |
Number | Date | Country |
---|---|---|
550575 | Mar 1986 | AU |
745271 | Mar 2002 | AU |
755496 | Dec 2002 | AU |
2005436 | Jun 1990 | CA |
26 40 413 | Mar 1978 | DE |
43 06 478 | Sep 1994 | DE |
29 504 378 | Sep 1995 | DE |
0100148 | Feb 1984 | EP |
0117632 | Sep 1984 | EP |
0161865 | Nov 1985 | EP |
0358302 | Mar 1990 | EP |
1018967 | Jul 2000 | EP |
692578 | Jun 1953 | GB |
2 195 255 | Apr 1988 | GB |
2 197 789 | Jun 1988 | GB |
2 220 357 | Jan 1990 | GB |
2 235 877 | Mar 1991 | GB |
2 329 127 | Mar 1999 | GB |
2 333 965 | Aug 1999 | GB |
4129536 | Aug 2008 | JP |
71559 | Apr 2002 | SG |
8002182 | Oct 1980 | WO |
8704626 | Aug 1987 | WO |
90010424 | Sep 1990 | WO |
93009727 | May 1993 | WO |
94020041 | Sep 1994 | WO |
9605873 | Feb 1996 | WO |
9718007 | May 1997 | WO |
9913793 | Mar 1999 | WO |
Entry |
---|
Louis C. Argenta, MD and Michael J. Morykwas, PHD; Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience; Annals of Plastic Surgery; vol. 38, No. 6, Jun. 1997; pp. 563-576. |
Susan Mendez-Eatmen, RN; “When wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. |
James H. Blackburn II, MD et al.: Negative-Pressure Dressings as a Bolster for Skin Grafts; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457; Lippincott Williams & Wilkins, Inc., Philidelphia, PA, USA. |
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. |
S.E. Greer, et al. “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), 53, pp. 484-487. |
George V. Letsou, MD., et al.; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639. |
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. |
International Search Report for PCT International Application PCT/GB95/01983; dated Nov. 23, 1995. |
PCT International Search Report for PCT International Application PCT/GB98/02713; dated Jan. 8, 1999. |
PCT Written Opinion; PCT International Application PCT/GB98/02713; dated Jun. 8, 1999. |
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; dated Jan. 15, 1998 & dated Apr. 29, 1997. |
PCT Written Opinion, PCT International Application PCT/GB96/02802; dated Sep. 3, 1997. |
Dattilo, Philip P., Jr., et al.; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture” Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. |
Kostyuchenok, B.M., et al.; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. |
Davydov, Yu. A., et al.; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. |
Yusupov. Yu.N., et al.; “Active Wound Drainage”, Vestnki Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. |
Davydov, Yu.A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds” Vestnik Khirugi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. |
Davydov, Yu.A., et al.; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof. |
Chariker, Mark E., M.D., et al.; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. |
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, pp. 2. |
Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. |
Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., No. 19, 1985, pp. 211-213. |
Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. |
Svedman, P. et al: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous of Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986); pp. 94-96 (certified translation). |
K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246. |
G. {hacek over (Z)}ivadinovi?, V. ?uki?, {hacek over (Z)}. Maksimovi?, ?. Radak, and P. Pe{hacek over (s)}ka, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (certified translation). |
F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. |
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (certified translation). |
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. |
D.E. Tribble, An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery 105 (1972) pp. 511-513. |
M.J. Morykwas, L.C. Argenta, E.I. Shelton-Brown, and W. McGuirt, “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997), pp. 553-562 (Morykwas I). |
C.E. Tennants, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. |
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211. |
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) (“Solovev Guidelines”). |
V.A. Kuznetsov & N.a. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 (“Bagautdinov II”). |
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). |
V.A.C. ® Therapy Clinical Guidelines: A Reference Source for Clinicians; Jul. 2007. |
Number | Date | Country | |
---|---|---|---|
20200160754 A1 | May 2020 | US |
Number | Date | Country | |
---|---|---|---|
62767822 | Nov 2018 | US |